Suppr超能文献

PFA-100(®) 的能力验证/外部质量保证。

Proficiency testing/external quality assurance for the PFA-100(®).

机构信息

Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, NSW, Australia.

出版信息

Clin Chem Lab Med. 2012 Feb 15;50(8):1393-401. doi: 10.1515/cclm-2012-0002.

Abstract

BACKGROUND

Platelet function testing is integral to haemostasis investigations and the Platelet Function Analyser-100 (PFA-100(®)) is globally the most utilised primary haemostasis-screening instrument. External Quality Assurance (EQA) (or proficiency testing) is critical to ensuring quality of test practice, but EQA for platelet function is logistically challenging and actual test-challenges generally not possible.

METHODS

A novel approach was therefore developed whereby a range of formulated test tubes are distributed to EQA participants to which citrated normal whole blood collected on site is added, thereby creating test material that can be locally evaluated. Several exercises have been conducted over the past four years (total of 18 challenges, most designed to mimic an aspirin effect or a mild or severe primary haemostasis defect, tested in 26-47 laboratories).

RESULTS

Numerical results for PFA-100(®) closure times (CTs) and interpretive comments provided by participants were analysed. Reported CTs for each challenge were within limits of expectation and good reproducibility was evidenced by repeated challenges. Coefficients of variation (CVs) generated for two PFA-100(®) cartridge types (C/ADP and C/Epi) for challenges [median (range): 14.8 (3.9-29.5) and 13.9 (0.6-29.5)] was similar to those obtained using native whole blood [15.6 (14.2-18.9) and 17.3 (13.5-20.5)]. Interpretations were in general also consistent with expectations and test data provided by laboratories.

CONCLUSIONS

In conclusion, an EQA process for the PFA-100(®) has been developed that includes a highly reproducible test-challenge process, not only proving the concept is possible for platelet function testing, but also providing a valuable mechanism for monitoring and improving laboratory performance.

摘要

背景

血小板功能检测是止血研究的重要组成部分,全球范围内应用最广泛的原发性止血筛选仪器是血小板功能分析仪-100(PFA-100(®))。外部质量保证(EQA)(或能力验证)对于确保测试实践的质量至关重要,但血小板功能的 EQA 在物流方面具有挑战性,并且通常无法进行实际的测试挑战。

方法

因此,开发了一种新方法,即将一系列配方测试管分发给 EQA 参与者,在现场采集枸橼酸盐正常全血添加到这些测试管中,从而创建可在当地评估的测试材料。在过去四年中进行了多次练习(总共 18 次挑战,大多数旨在模拟阿司匹林效应或轻度或重度原发性止血缺陷,在 26-47 个实验室中进行测试)。

结果

分析了参与者提供的 PFA-100(®) 闭合时间(CT)的数值结果和解释性评论。每个挑战的报告 CT 均在预期范围内,并且通过重复挑战证明了良好的可重复性。两种 PFA-100(®) 测试卡类型(C/ADP 和 C/Epi)的挑战产生的变异系数(CV)[中位数(范围):14.8(3.9-29.5)和 13.9(0.6-29.5)]与使用天然全血获得的 CV 相似[15.6(14.2-18.9)和 17.3(13.5-20.5)]。解释通常也与预期和实验室提供的测试数据一致。

结论

总之,已经开发出一种 PFA-100(®) 的 EQA 流程,其中包括高度可重复的测试挑战流程,不仅证明了血小板功能测试的概念是可行的,而且还为监测和提高实验室性能提供了有价值的机制。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验